We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$163M
AUM Growth
+$7.91M
Cap. Flow
-$529K
Cap. Flow %
-0.32%
Top 10 Hldgs %
60.11%
Holding
50
New
1
Increased
10
Reduced
36
Closed
–

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$186K
2
ALXN
Alexion Pharmaceuticals
ALXN
+$52.5K
3
BIDU icon
Baidu
BIDU
+$50.2K
4
GILD icon
Gilead Sciences
GILD
+$31.9K
5
BIIB icon
Biogen
BIIB
+$26.2K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$138K
2
VIPS icon
Vipshop
VIPS
+$75.9K
3
WBA
Walgreens Boots Alliance
WBA
+$55.5K
4
ISRG icon
Intuitive Surgical
ISRG
+$51.9K
5
BIVV
Bioverativ Inc. Common Stock
BIVV
+$47.3K

Sector Composition

Rank Sector Weight
1 Healthcare 33.52%
2 Consumer Discretionary 27.17%
3 Technology 22.14%
4 Communication Services 12.71%
5 Industrials 2.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.95T
$20.3M 12.44%
563,584
-3,720
-0.7% -$138K
ISRG icon
2
Intuitive Surgical
ISRG
$128B
$12.4M 7.63%
119,637
-540
-0.4% -$51.9K
CELG
3
DELISTED
Celgene Corp
CELG
$10.9M 6.71%
84,251
-244
-0.3% -$29.9K
ILMN icon
4
Illumina
ILMN
$28.7B
$9.79M 6%
58,005
+115
+0.2% +$19.9K
ULTA icon
5
Ulta Beauty
ULTA
$20.7B
$8.6M 5.27%
29,911
-143
-0.5% -$41.7K
META icon
6
Meta Platforms (Facebook)
META
$1.51T
$8.51M 5.22%
56,343
-5
-0% -$743
AMZN icon
7
Amazon
AMZN
$2.49T
$8.33M 5.11%
172,200
-120
-0.1% -$5.72K
GILD icon
8
Gilead Sciences
GILD
$162B
$6.82M 4.18%
96,371
+480
+0.5% +$31.9K
CTSH icon
9
Cognizant
CTSH
$22.3B
$6.4M 3.93%
96,401
-687
-0.7% -$43.6K
MELI icon
10
Mercado Libre
MELI
$92.3B
$5.91M 3.62%
23,551
-153
-0.6% -$39.3K
VIPS icon
11
Vipshop
VIPS
$7.08B
$5.45M 3.34%
183,522
-5,805
-3% -$75.9K
BKNG icon
12
Booking.com
BKNG
$145B
$5.1M 3.13%
68,200
-225
-0.3% -$16.5K
LULU icon
13
lululemon athletica
LULU
$13.4B
$5.02M 3.08%
84,141
+302
+0.4% +$15.7K
GOOG icon
14
Alphabet (Google) Class C
GOOG
$3.99T
$5.01M 3.07%
110,260
-360
-0.3% -$16.5K
CAVM
15
DELISTED
Cavium, Inc.
CAVM
$4.76M 2.92%
76,688
-40
-0.1% -$2.79K
ABBV icon
16
AbbVie
ABBV
$454B
$4.29M 2.63%
59,231
+10
+0% +$672
SBUX icon
17
Starbucks
SBUX
$118B
$4.22M 2.59%
72,448
-29
-0% -$1.75K
VMW
18
DELISTED
VMware, Inc
VMW
$4M 2.45%
45,708
+85
+0.2% +$7.84K
ALXN
19
DELISTED
Alexion Pharmaceuticals
ALXN
$3.95M 2.42%
32,460
+451
+1% +$52.5K
GOOGL icon
20
Alphabet (Google) Class A
GOOGL
$3.99T
$3.73M 2.29%
80,360
-340
-0.4% -$15.9K
BIDU icon
21
Baidu
BIDU
$35.8B
$2.7M 1.66%
15,117
+277
+2% +$50.2K
BIIB icon
22
Biogen
BIIB
$29.5B
$2.53M 1.55%
9,335
+99
+1% +$26.2K
PRLB icon
23
Protolabs
PRLB
$1.85B
$2.18M 1.34%
32,382
+65
+0.2% +$3.93K
BA icon
24
Boeing
BA
$167B
$918K 0.56%
4,641
-95
-2% -$17.7K
HD icon
25
Home Depot
HD
$335B
$887K 0.54%
5,780
-120
-2% -$18.4K
1
2

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
KPWG
KFA Private Wealth Group Tysons, Virginia $417M AUM 16.82% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return

Bender Robert & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Bender Robert & Associates held 50 positions worth $163M, up 5.1% from $155M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 2%. Bender Robert & Associates opened 1 new position and made no exits, leaving the 50-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bender Robert & Associates's largest Q2 2017 buy was Oracle: 4,092 shares worth $205K.
  • Bender Robert & Associates added most to Alexion Pharmaceuticals in Q2 2017, an estimated $52.5K increase.
  • Bender Robert & Associates's biggest Q2 2017 reduction was Apple, cutting an estimated $138K.
  • Bender Robert & Associates's ten largest holdings make up 60% of its $163M portfolio in Q2 2017.
  • Bender Robert & Associates opened 1 new position and closed 0 in Q2 2017.
  • Bender Robert & Associates's portfolio value rose 5.1% quarter-over-quarter to $163M.

Based on Bender Robert & Associates's 13F filing for Q2 2017, filed 3 Aug 2017.